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P R E F A C E 
The Counc1l of the European CoiT@Un1ties has adopted 1n 1979 the First 
Act1on Programme on Safety and Health at Work to be comprehensive at 
Community level. This AcLion Programme sets out a number of priorities 
many of whlch emphasize the need to 1ncrease protect1on aga1nst dange-
rous substances. 
The need to promote new mon1tor1ng and measuring methods for the assess-
ment of 1nd1vidual exposure, 1n part1cular through the appl1cat1on of 
sensltive biological 1nd1cators lS stressed. 
These monographs are a1med at provid1ng the pract1c1ng occupat1onal 
doctor with up-to-date information on the poss1b1l1ties and limitations 
of biolog1cal mon1tor1ng for a number of agents. 
The advent of modern micro-analytic techniques, the increased automa-
tizat1on of methods and our better understand1ng of b1ochemical pro-
cesses have allowed the development and multiplication of biolog1cal 
tests for the early detectlon of 11 excessive 11 exposure to industrial 
chem1cals and hence for preventing occupational diseases. 
Human biolog1cal monitoring, 1n the context of these monographs, is the 
evaluation of occupational exposure to chemical agents using the exposed 
worker h1mself. The analytical determination will be carried out on 
representat1ve biological mater1als (1ndicator media) of the exposed 
organ1sm, 1t will e1ther consist of the determ1nation of the toxic agent 
itself or 1ts metabolites or some early reversible biological effects 
which are cons1dered useful for the prevent1on of excessive exposure. 
The biolog1cal monitoring approaches described in these monographs are 
not indicated as health screening procedures aimed at detecting cl1nical 
effects. Biological monitoring may be complementary to monitoring of 
the working environment and in several situations may be the most rele-
vant approach. 
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Blological monltoring provldes an lndlrect lnslght lnto what happens 
inside the body of exposed workers, and some more relevant parameters 
for estimatlng the rlsk of health lmpairment, by 
taklng into account total exposure (via the resplratory tract, the 
skln and the gastro-intestlnal tract). 
taking into account various host factors affecting pharmacokinetics 
and pharmacodynamlcs. 
Some biologlcal monitoring tests are best used for lndlvldual screenlng 
wh1le some are best su1ted for group exposure conditions. 
Biological lndlcators are at present avallable for only a small number 
of toxic agents and furthermore the procedures for biological monitoring 
are limited also by the avallability of excreta and readlly accesslble 
body flulds and tlssues for analysls. 
RegardJ_ng these biological materlals emphasls must be placed on the 
precautions which must be taken ln handllng these materlals before and 
dur1ng analys1s. Care must also be taken with the 1nterpretation of 
the results, taking lnto account the always possible analytlcal errors, 
and the biological variabillty from indlvidual to lndivldual. Finally, 
it should be kept ln mlnd that excessive exposure does not necessarily 
mean health lmpairment. 
It must be recognlzed that the blological monitoring approach has not 
yet reached a very advanced stage of development and that conslderable 
research is still necessary. Thls is reflected by the monographs which 
are publlshed in this series and which reflect the current state of 
knowledge in this field taking only into consideration relevant human 
data. 
Dr. P. Recht 
D1rector. 
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ABBREVIATIONS 
1) ALAO 6-aminolevulinic acid dehydratase activity of erythrocytes 
2) ALAU 6-aminolevulinic acid in urine 
3) CPU Urinary coproporphyrin _ 
4) EP Erythrocyte protoporphyrin 
5) PbA Atmosrheric lead levels 
6) PbB Lead in blood 
7) PbU = Urinary Leaa 
8) PbUEDTA = Amount of chelatable lead excreted with 24-h urine after administration 
of CaNa2 EDTA (l g intravenously) 
9) ZPP = Erythrocyte Zinc protoporphyrin 
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1.0 SUMMARY 
This document reviews inorganic lead as related to occupational exposure and the 
possibilities of the biological monitoring of exposure. 
The main route of absorption in occupational exposure is the respiratory 
apparatus. Derangement in heme synthesis is currently considered the first adverse 
effect associated with increasing concentration of lead in the soft tissues. 
A vast number of tests which permit an evaluation of the degree of exposure, body 
burden, and toxic effect are available for monitoring lead workers. 
For periodic monitoring of workers exposed to lead it is recommended that two tests 
be used simultaneously; one test should be designed to indicate internal dose and 
another to indicate effect. In general it is adv~sable to use blood lead levels as 
a measure of internal dose, and erythrocyte protoporphyrin as an indicator of 
effect. 
For screening studies an inexpensive test which is easy to perform, sensitive, 
specific and precise should be used to identify subjects with high exposure. Both 
protoporphyrin and delta-aminolevulinic acid dehydratase comply with these 
requirements. 
For assessment on a group analysis basis of the environmental condition of a work 
place, the urinary tests may be used; blood tests, however, provide more accurate 
information. 
Individual blQod lead levels in male workers should not exceed 60 llg/100 ml, and 
in women workers of child-bearing age they should not be higher than 40 llg/100 ml 
because of the potential adverse effect of lead on the foetus. 
Further investigations are required on the relationship between external and 
internal dose and standardization of the various biological tests. 
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2.0 INTRODUCTION 
2.1 Chemical and physical properties 
Lead is a chemical element represented by the symbol Pb and with an atomic number 
of 82, atomic weight 207.21, specific weight 11.342. Melting point: 327°C; boiling 
point: about l740°C. Starting from temperatures of 550-600°C, there is 
considerable production of vapours which combine with oxygen in the air to form 
lead oxide. Lead is found in the natural state in mineral deposits. The most 
common and most widely used mineral for extraction is galena (PbS). The lead 
content in directly mined mineral varies from 3 to 10%. 
2.2 Effects on Humans 
Derangement in heme synthesis is currently considered the first adverse effect 
(critical effect) associated with increasing concentration of lead in the soft 
tissues; in fact, lead can inhibit some enzymatic activities of heme biosynthesis 
(Chisolm, 1971; De Bruin, 1971; Baloh, 1974; Waldron and Stoefen, 1974). See Figure 
l (Chisolm, 1971). 
The inhibition by lead of ALAD and heme synthetase, which are enzymes containing SH 
groups, is well documented. Due to ALAD inhibition, an accumulation of ALA occurs 
in the serum and consequently in the urine; inhibition of heme synthetase (iron 
chelatase) produces an accumulation of protoporphyrin IX in the erythrocytes. An 
increase in urinary coproporphyrins is an indirect evidence of coprogenase 
inhibition by lead. 
The combination of decreased delta-aminolevulinic acid dehydratase activity in red 
blood cells, increased urinary delta-aminolevulinic acid, increased urinary 
coproporphyrin, and increased erythrocyte protoporphyrin is pathognomonic for lead, 
distinguishing it from all other disorders of pyrrole metabolism in man (Chisolm, 
1975). 
Also changes in nerve conduction velocity should be regarded as a critical effect 
(Zielhuis, 1977). These changes will not, however, be considered here because the 
investigation methods are rather time-consuming, difficult to perform in working 
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environments, and are not yet standardized; furthermore, the individual results are 
not always reliable since the alterations are unspecific. Such investigations can 
nevertheless be very useful for studies on groups of workers. 
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3. 0 MET llBOLISM 
ln working environments the main route absorption is the respiratory apparatus. It 
IS generally consiaerea that 3~-~0% of the lead that reaches the lower respiratory 
tTact i:, absorbea into the blooo stream. 
The potential increase in the body burden ot lead can be expresseo as: 
BB = L X V x R x 0 x 10-3 
where BB=potential increase in body burden in mg; L=air lead concentration in 
mg/m 3; \!=pulmonary ventilation in m3 /day; R=fraction of inhaled lead retained; 
D=auration of exposure in oays. R values vary accoroing to the solubility and 
particle size of inuividual lead compounds. 
The uptake of leaa by the gastro-intestinal tract is less complete than by the 
lung. Not more than 5-10% ot Ingesteo lead is generally absorbed, the balance being 
excreted in the feces. 
A potential gastro-intestinal absorption in inoustry should not be underestimated. 
Both because it can increase oue to particular personal habits, e.g. smoking, 
eating in the work-place and because as much as 40% of inhaled lead of large 
dlameter trapped In the upper respiratory tract may be swallowed (Kehoe, 1961; 
Knelson et al., 1~7.5; hamilton ana Hardy, 1974; Waldron and Stoefen, 1974). 
ln a steady-state situation, lead Intake equals output and the skeletal system 
contains about 80-90% of the total boay buraen of lead. 
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Figure 1 
Biosynthesis of heme is inhibited by lead, resulting in 
accumulation of intermediates in the synthetic pathway. Lead 
inr1ibits two steps (solid arrows) and may inhibit two others 
(broken arrows). 
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Figure 2 (Baloh, 1974) gives a schematic representation of the dynamic interchange 
of the body lead pool. Blood is the major factor in determining the steady state 
distribution of lead in body tissues. There is a dynamic equilibrium between red 
cell lead and plasma lead on the one hand and between extracellular lead and 
intracellular lead on the other. It is likely to be the ionic fraction of the 
plasma lead which is transferred to the other body compartments. The equilibrium 
constants of the reactions probably rank in the following order: 
K4 > K3 > K2 > K1 . However, since a state of equilibrium is rarely reached, 
the rate constants Kf also become important. The rate constants indicate the 
speed with which the state of equilibrium can be reached in any given reaction. 
The rate constants in Figure 2 are probably in the reverse order of the equilibrium 
constants, i.e. , K fl > K f2 > K f3 > K f4, indicating that the bone 
takes more time to reach its final lead concentration than erythrocytes or proteins 
(Baloh, 1974; Waldron and Stoefen, 1974). 
According to Pietrovsky (1970) the total body burden of lead can be roughly divided 
into: 1) rapid e:<change pool in blood and soft tissues; 2) intermediate exchange 
pool in skin and muscles; 3) exchange pool in bone (intermediate exchange in bone 
marrow, trabeculae, and slow exchange in dense bone and teeth). 
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Figure 2 
The dynamic interchange of the body lead pool 
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4.0 BIOLOGICAL INDICATORS 
4.1 Indicators of Internal Lead Dose 
Dose should, ideally, be defined as "the amount or concentration of a given 
chemical at the site of its action", i.e., where its presence leads to a given 
effect. Since the determination of this amount is often impossible in practice, 
the dose may have to be estimated by various means and in most cases one can speak 
only in terms of these dosage estimates. Metal concentration in biological media 
can often be used as indicators (or indices) of exposure and of concentration in 
the critical organ (Nordberg, 1976). 
Below are considered the biological tests which may be used as indicators of an 
internal lead uose. 
4.1.1 Concentrations in blood 
The level of lead in blood (PbB) is a function of the quantity of lead absorbed 
from the environment minus the lead deposited in the bone cortex and soft tissues 
and the lead excreted with urine and feces (Waldron, 1971). PbB is about 2% of the 
total lead burden. Approximately 90% of blood lead is bound to erythrocytes and is 
not readily diffusible; plasma lead (0.2% of the total Durden) is made up of two 
fractions: the plasma protein bound fraction and the diffusible fraction, the 
latter being probably the metabolically active center of the body lead pool (Baloh, 
1974). See Figure 2. Diffusible plasma lead probably gives the best approximation 
of the biologically effective lead burden, although at present it is not possible 
to measure it. It should be noted, however, that the plasmatic fraction of lead is 
not a constant function of the total blood lead concentration and therefore cannot 
be predicted by PbB (Waldron, 1974). However, for groups of subjects, PbB is 
probably a reasonable indication of plasmatic levels (Zielhuis, l975a). 
In practice PbB is the most reliable means of measuring the extent of exposure: it 
allows distinctions to be made between "normal" subjects, subjects with 
"permissible" absorption levels, and subjects with "non-permissible" absorption 
levels. It is, moreover, particularly useful in epidemiological studies. In fact, 
a good correlation exists between PbB and lead levels in the atmosphere (Williams 
et al., 1969). 
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Interpretation of blood lead levels must take into account the fact that they 
reflect only one point in time, and a dose which is steady, increasing or 
decreasing (Nordberg, 1976). However, although these levels allow a satisfactory 
evaluation of current exposure, they are not necessarily always correlated with the 
lead body burden. In fact, after cessation of exposure, PbS may reach "normal" 
values while a body burden persists. This is demonstrated by a high urinary lead 
excretion after chelating therapy (Prerovska and Teisinger, 1970), or when 
disorders of heme synthesis are still evident (Selander and Cramer, 1970; Alessio 
et al. ,l976c). On the other hand, cases are known in literature of adults and 
children who showed clinical symptoms of intoxication but who had relatively low 
PbS values (Beritic, 1971; Moncrieff et al., 1964). This apparent "paradox" could 
be due to the fact that measurement occurred some time after cessation of exposure 
(Kehoe, 1972) . 
Studies on volunteers who received different quantities of lead also showed that 
the PbS levels reach a given ceiling even when the body lead burden increases 
continuously during exposure (Kehoe, 1961). This was also observed in occupational 
exposure (Benson et al., 1976). 
Factors exist which can influence PbS levels independently of exposure and body 
burden. For example, blood lead levels are greatly affected by the red blood cell 
mass (anemia, polycythaemia). There has been much discussion of whether these 
levels should be corrected according to the haematocrit values, but there is 
disagreement on the biological validity of such correction (Lauwerys, 1975). 
Further, the measurement of lead concentration in blood also presents difficulties 
(Berlin et al., 1974; WHO, 1977; NIOSH, 1978). According to Baloh (1974), there is 
a 15% error in. the measured value on multiple runs of the same blood sample even in 
the most competent laboratories. A number of interlaboratory control programs have 
revealed high rates of variation in the results, which are probably due to the fact 
that this parameter is measured with methods and instruments that differ 
considerably one from the other. In January 1978, an interlaboratory control 
program for PbS was sponsored by the EEC (within the frame of the activities 
provided for in the EEC guidelines of 29.3.77)~ This program is still under way 
and preliminary results indicate that the extractive methods followed by flame AAS 
always gives lower results than the other techniques with atomic absorption. The 
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flameless methods or the "Delves Cup" give similar results but it should be noted 
that the "Delves Cup" tends to overestimate the values. 
4.1.2 Concentrations in urine 
The kidney is presumed to excrete lead by two routes: glomerular filtration and 
transtubular flow or excretion (Vostal and Heller, 1968) 
The relative importance of the two routes is uncertain, but the formation of lead 
containing inclusion bodies suggests that in subjects with heavy lead exposure, 
transtubular flow may assume a greater importance (Cramer et al., 1974). 
Since the analysis of lead in urine (PbU) does not require blood withdrawal, it is 
sometimes preferred to PbS determination (Lauwerys, 1975). The "normal" PbU 
concentration in adults usually oscillates between 10 and 80~g/l, lower than 
50~g/g creatinine (Salah, 1974; Lauwerys, 1975). In subjects under continuous 
exposure, a satisfactory correlation was found between atmospheric lead levels and 
PbU and between PbS and PbU (Williams et al. , 1969). In the case of new lead 
exposure there is also a good correlation between PbS and PbU, but while PbS 
increases without any demonstrable time lag, the increase in PbU requires a latency 
period of about 2 weeks (Tala et al., 1973). 
Many factors other than lead absorption such as fluid intake and speci fie gravity 
of the urine may influence the excretion of lead (Ellis, 1966). Patients with 
chronic nephritis frequently have PbU levels within "normal" limits in spite of the 
existence of high lead stores (Lilis et al., 1968). Prerovska and Teisinger (1970) 
have demonstrated that subjects with heavy lead exposure in the past can have 
normal urinary lead excretion even when excretion of chelatable lead remains high. 
4.1.3 Concentration in feces 
In the non-occupationally exposed general population the quantity of lead 
eliminated with the feces is clearly higher than that eliminated with the urine. 
In fact, the greater part of the metal present in the feces consists of ingested 
lead that has not been absorbed by the intestines (Kehoe, 1961). 
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The levels of lead in feces of "normal" subjects varies between 240 and 400llgl24h 
(Kehoe, 1961; Barry, 1975). Our ing occupational exposure the values increase to 
760-3800llg/24h, according to the data of Saita and Moree (1958). 
Measurement of lead in feces can be used to determine absorption by ingestion 
(accidental or intentional). Fecal lead excretion above 4mg/l00g, 4 weeks after 
occupational exposure has ceased, is a sure indication of ingestion ( Zielhuis, 
1972). The analysis is valid only when perfor~ed during the period of ingestion or 
in the days immediately following (Vigliani and Debernardi, 1934). 
4.1.4 Chelatable lead 
Chelatable lead is strictly dependent on the active deposit of the metal in the 
soft tissues of the body, including the trabecular bone (Teisinger et al., 1969), 
and as a result it provides a more direct measurement of the rapid exchange pool. 
Chelatable lead can be measured by injections of CaNa2 EDTA or by penicillamine 
per os. The levels of PbU EDTA (mean + 2 SO) in 26 inhabitants of Milan who were 
not occupationally exposed to lead, were 630llg/24h (Alessio et al., l976a). 
Limited data on humans strongly suggest that the CaNa2 EDTA mobilization test may 
be a better indication of the concentration of lead in affected organs of man 
(Nordberg, 1976). 
Since CaNa2 EDTA is capable of binding only with extracellular lead, (Teisinger 
et al., 1958; Castellino e Aloj, 1965), it is likely that measurement of metal in 
urine after administration of this drug permits an indirect, though rough, 
evaluation of tre levels of diffusible lead. 
After administration of CaNa2 EDTA, the reduction in levels of lead in the plasma 
creates a cells/plasma gradient which slowly disappears. After the first few days 
of treatment in fact, urinary lead is greatly reduced and it is necessary to 
interrupt administration for a few days so that an equilibrium may be established 
in the distribution of lead in the cellular and extracellular compartments and so 
that a high excretion of the metal may once again be obtained (Saita, 1962). 
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In studies on children and adolescents (Chisolm et al., 1976), a statistically 
significant linear relationship was found between blood lead concentration and the 
logarithm of the quantity of lead excreted in the 24-hour period immediately 
following administration of CaNa2 EDTA. In our laboratory, studies in progress 
have shown that a good correlation exists between PbB and PbU EDTA 1n adult 
subjects with current occupational exposure to lead. In subjects with past 
occupational exposure, the correlation between the two parameters is definitely 
lower, although still statistically significant. Analysis of the regression curves 
shows that for corresponding values of chelatable lead, subjects with past exposure 
have lower blood lead levels than currently exposed subjects. The slopes of the 
regression lines are statistically different (Figure 3). 
Chelatable lead cannot be used in epidemiological studies because it necessitates 
administering a druy and also because 24-hour urine samples are difficult to obtain. 
The induced urinary lead test is capable of detecting and evaluating the existence 
of lead absorption which occurred in the past. It can therefore be used to 
determine whether former acute manifestations or current chronic manifestations are 
attributable to lead intoxication, even when the other indicators of internal dose 
have returned to normal (Saita, 1962; Prerovska and Teisinger, 1970). 
Teisinger (1971) maintains that in subjects with past exposure, a urinary lead 
excretion above lmg/24h after administration of CaNa2 EOTA (2g i.v.) is 
indicative of a potentially dangerous body burden of the metal; for subjects still 
exposed, however, the author sets this critical level at 2mg/24h. 
4.1.5 Relationship between external lead exposure and indicators of internal dose 
Many studies have demonstrated the existence of a correlation between PbB, PbU and 
the atmospheric lead levels in the working environment (PbA). 
The relationship between PbA 
atmospheric lead levels are low 
1976). See Figure 4. Williams et 
and PbB (r=0.90) and between 
and PbB has a similar profile both when the 
and when levels of 0 .2mg/m3 are reached (Harada, 
al. ( 1969) found a close correlation between PbA 
PbA and PbU (r=0.82) with high statistical 
significance (p<O.Ol). Table 1 (Williams et al., 1969) gives the mean values ana 
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Figure 4 
Relationships between lead concentration in air and lead concentration in blood 
of lead workers. The curves are those obtained from a study of the PbA/PbB 
relationship in newspaper industries (Harada, 1976), extended to plot also the 
values of Elkins (1959), Harada et al. (1960) and Tsuchiya and Harashima (1965). 
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Table 1 
Mean values and 95% confidence limits of single determinations of 
lead in blood and urine which correspond to two 
lead-in-air concentrations. 
0.20 Mean 
95% C.L. 
0.15 Mean 
95% C.L. 
PbB 
( ~g/100 ml) 
70 
48-92 
60 
38-82 
PbU 
( ~g/1) 
143 
56-230 
118 
31-205 
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the 95% confidence limits of single determinations of PbB and PbU which correspond 
to 0.2 and O.l5mg;m3 lead in air. The wide range of the confidence limits is 
evident from these data. 
On the basis of Williams' data, Zielhuis and Verberk (1974) examined the validity 
of various PbB and PbU levels as indicators of "unacceptable" exposure; they 
assumed PbA=0.12mg/m3 to be the "acceptable" level. See Table 2. In this sample, 
for the cut-offs considered, PbB levels have a higher validity than PbU levels as 
indicators of unacceptable exposure. PbB > 40 has maximum sensitivity (no false 
negatives: all individuals with PbA > 0.12 have PbB > 40); however, specificity 
is moderate (also PbB > 40 in subjects with PbA < 0.12: 44% of false 
positives). PbB > 80 is highly specific (no individual with PbA < 0.12 has PbB 
> 80, i.e., no false positives); but sensitivity is moderate (46% false 
negatives). On the basis of these results, Zielhuis and Verberk (1974) conclude: 
"If one wants to be certain that all subjects with PbA > 0.12 are selected out of 
a universe of exposed workers, PbB > 40 will serve this objective, however, at 
the cost of a number of false positives. If, on the other hand, one wants to select 
only individuals with PbA > 0.12, then PbB > 80 will serve this objective, 
however with many false negatives." 
The number of subjects in whom validity has been studied is limited (about 30 
cases) but it is likely that even with a larger number of subjects the validity 
values will be similar since air sampling involves many limitations; i.e.: 
effect of particle size and solubility of particle; 
representation of only a small fraction of total volume of air inhaled; 
ingestion remains unmeasured; 
effect of contamination and position of sampling head; 
effect of the entry of particulates into sampling heads; 
failure to evaluate individual differences in pharmacokinetics according 
to age, type of respiration, congenital or acquired diseases, etc. (Lyman, 
1975). 
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Table 2 
Validity of different PbB and PbU levels for predicting 
an unacceptable lead exposure (PbAir 
PbB >40 
~g/100 ml >60 
>80 
PbU > 60 
~g/1 >120 
>160 
Se = sensitivity 
Sp = specificity 
Sp + Se = Validity 
Se Sp 
1.00 0.66 
0.72 0.80 
0.56 1.00 
0.88 0.53 
0.56 0.95 
0.12 0.95 
0 .l2mg/m3) 
validity 
1.66 
1.52 
1.56 
1.41 
1.51 
1.07 
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At the 2nd International Workshop on Permissible Limits for Occupational Exposure 
to Lead (Zielhuis, 1977), the conclusion was reached that a "standard" for lead in 
air based upon the relationship between PbB and PbA could not be established. Such 
a standard, it was felt, would best be based on PbB alone. 
To conclude this section, it seems appropriate to make the following points: 
a) Lead in the blood and lead in the urine are indicators of exposure since the 
levels of these parameters are closely influenced by the environmental 
concentration of lead. 
b) Chelatable lead may be considered a "true" indicator of dose, the levels of 
which reflect the active lead deposit. 
c) In currently exposed subjects the indicators of exposure permit prediction of 
the quantity of chelated lead. 
d) In subjects no longer exposed the indicators of exposure do not permit a 
reliable evaluation to be made of chelatable lead. 
4.2 Indicators of Effects in Adult Males 
Biological tests which may be used as indicators of a biological leaa effect are 
separated according to sex since in recent years it has been shown that some 
indicators of effect behave differently in males and females. 
4.2.1 Erythrocyte delta-aminolevulinic acid dehydratase (ALAD) 
The ALAD activity of circulating erythrocytes is highly sensitive to inhibition by 
leaa; inhibition of ALAD il"1 red blood cells (RBC 's) parallels inhibition in other 
tissues, e.g., liver (Secchi et al., 1974). 
A very close negative correlation exists between erythrocyte ALAD and lead blood 
levels (PbB). The enzyme undergoes distinct inhibition in the range of PbB values 
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below 40~g/l00nl (Hernberg et al., 1970 Haeger-Aronsen et al., 1971; Zielhuis, 
15172; Lauwerys et al., 1974). There is suggestive evidence that the no-effect 
level is about lO~g PbB/lOOml (Granick et al., 1973). 
Up to 15174, studies on the relationship between ALAD and PbS have generally used 
the method of Bonsignore et al. (1965) or methods derived from this for the 
determination of ALAD. At present the European stanoardized method (Berlin and 
Schaller, 1974) is widely used. Determination of ALAD using the method of 
Bonsignore is of little use in monitoring occupationally exposed subjects (Alessio 
et al., l517bb). See Figure 5. In fact, when PbS increases beyond 40~g/l00ml, the 
enzymatic activity is reduced to a level too low to allow identification of 
different blooo leao levels (oe Bruin, 1968; Basecqz et al., 1971; Hernberg et al, 
197<:; Sec chi and Alessio, 1974). However, ALAD can have a wider application in 
monitoring leao workers when it is measured with the CEC method, since a marked 
inh1bition of the enzymatic levels occurs only when PbB values exceed 
50-60~g/l00ml. See Figure 5. 
Valiaity of ALAD is rathEor moaerate for PbB levels lower than 40~g/l00ml which 
therefore 1mplies a very high percentage of false classifications. Thus when 
subjects with only environmental lead exposure are studied according to Ziehluis 
(1974), "it is not possible to base a biological quality guide on individual ALAD 
levels". Validity of ALAD does, however, improve markedly for higher PbS levels. 
For example, the validity of ALAD (measured with the CEC method) is good at a PbS 
cut-off of 60~g/l00ml. At this PbS level, at a cut-off of 15~/RSC the enzyme 
displays a sensitivity of 0.96 (i.e. 4% false negatives) and a specificity of 0.85 
(i.e., 15% false positives). These data indicate that ALAD may be used as a 
screening test for occupationally exposed subjects (Table 3). 
After a worker's first exposure to lead, ALAD activity decreases rapidly without 
any appreciable time lag, parallel to the increase in blood lead concentration 
(Hernberg et al., 1972). According to Tala (1972) and Haeger-Aronsen et al. 
(1974), when exposure to lead ceases, ALAD activity progressively returns to 
normal, parallel to PbS. Thus, according to these findings, ALAD does not indicate 
any former lead exposure that cannot be detected from an elevation of PbS. 
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Table 3 
Validity of ALAD for Predicting Different PbB Levels. Analysis made on 
108 adult males currently exposed to lead 
PbB ALAD 
~9/lOOml mU/ml RBC Se Sp Validity 
~ 40 :;: 20 0.71 0.80 1.51 
~ 60 :;: 15 0.96 0.85 1.81 
~ 70 :;: 10 0.94 0.92 1.86 
Se = sensitivity, Sp specificity, Validity = Se + Sp. ALAD 
determined according to the European standardized method. 
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However, other studies (Vergnano et al., 1969; Sakurai et al., 1974) indicate to 
the contrary, that in cases of severe past exposure, ALAD remains inhibited out of 
proportion to the current PbB. It has been conjectured that 1n th1s situation 
enzymatic inhibition is oue to an inhibitor other than lead, probably of a 
thermolabile proteic nature (Vergnano et al., 1969). 
The significance of erythrocyte ALAD inhibition due to lead 1n regard to health is 
still open to discussion ( Zielhuis, 197 5a). As regards ALAD inhibition for the 
range of PbB up to 40ug/l00ml ''its bioloqic8l significance is dubious because it 
is unaccompanied by any detectable effects on the biochemical function of man" 
(NAS, 1972). According to Nordberg (1976), an inhibition ot ALAD in the cells of 
the bone marrow is a subcritical effect which precedes an increased level of 
delta-aminolevulinic acid in blood and urine and the occurrence of anemia (critical 
effects). A decrease in ALAD activity in blood is an example of an 1ndicator of 
subcritical effect of lead exposure. 
Until recently, it was not clear whetr1er the inhibition of peripheral erythrocyte 
ALAD by lead was a phenomenon which really occurred in vivo, or a pnenomenon which 
only occurred in vitro, i.e. a result of membrane-bound lead getting access to the 
intracellular enzyme as a result of haemolysis in the test tube required for 
determining ALAO activity. Roels et al. (l974a) have shown that the decrease in the 
erythrocyte enzyme is a true reflection of the enzyme activity in yivo when PbB is 
l?Oug/lOOml. ALAD inhibition is highly specific for increased leaa absorption: 
e.g. no reduction of ALAD activity has been observed in workers occupationally 
exposed to cadmium and mercury (Lauwerys et al., 1974; Lauwerys and Buchet, 1973). 
A transitory inhibition of ALAD occurs after acute ingestion of high quantities of 
alcohol, and returns to normal with the normalization of blood alcohol (Moore et 
al., 1971). In chronic alcoholism high PbB values may be found, but ALAD appears 
more depressed than might be expected from blood lead levels, and these levels 
remain low for a number of days after suspension of alcohol consumption (Krasner et 
al., 1974: Secchi and Alessio, l974a). 
In lead-exposed subjects, false negative results of ALAD may be obtained when 
hyper-regenerative erythropoietic disorders exist, e.g. bleeding anaemia, 
haemolytic anaemia (Bonsignore et al., 1970; Battistini et al., 1971). 
The European standardized method for determination of ALAD proved to be accurate 
and with good reproducibility. The interlaboratory coefficient of variation in the 
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intercomparison programme sponsored by the CEC in 1974 was 10% (Berlin et al., 
1974). 
In the view of Berlin and Schaller (1974), the routine use of ALAD is limited by 
technical problems, particularly the conservation of the blood sample at 0°C for a 
limited time interval. In our experience, when the sample is stored at 4°C, no 
loss of enzyme occurs after 24 hours . See Table 4. 
Table 4 
Erythrocyte ALAD activity (m U/ml) before and after storage at 4°C 
samples before storage after storage 
24 hours 48 hours 
1 38.0 37.6 33.0 
2 21.4 20.8 17.2 
3 19.8 19.9 16.2 
4 16.0 16.0 13.0 
5 9.8 9.7 9.0 
4.2.2 Erythrocyte Protoporphyrin IX 
Heme synthetase is extremely sensitive to the action of lead and the inhibition of 
this enzymatic activity causes an accumulation of EP in erythrocytes. This is 
related to t[le fact that the mitochondrial enzyme regulates the incorporation of 
iron in the porphyrin molecule. In occupationally exposed subjects, the 
concentration of this erythrocyte metabolite rises and can reach levels from 10 to 
50 times higher than the values found in subjects not occupationally exposed to 
lead (Vigliani and Angeleri, 1935; Rubino et al., 1958, de Bruin, 1971). 
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The methods of erythrocyte protoporphyrin determination are numerous. Some permit 
selective measurement of different porphyrins (Schwatz and Wikoff, 1952; Sassa et 
al., 1973), others measure the total concentration of erytrocyte porphyrins 
(Piomelli et al., 1973). All these methods use extractive techniques. 
The discovery that erythrocyte protoporhyrin that rises following an abnormal lead 
absorption (or following sideropenia) is not "free" but bound to zinc, 
revolutionized the determination methods. In fact, zinc protoporphirin can be 
determineD on capillary blood diluted with water or alcohol by direct fluorimetric 
reading (Lamola, 1974). Since 1976 instruments have been developed 
hematofluorimeters - for the immediate determination of zinc protoporphyrin on 
undiluted blood (Blumberg et al., 1977). 
Henceforth, protoporphyrin determined with extractive methods will be shown as EP 
and zinc protoporphyrin as ZPP. 
For greater clarity, EP and ZPP are dealt with separately. 
4.2.2.1 Erythrocyte protoporphyrin determined with extractive methods 
EP measurement has made considerable advances in paediatrics as a result of studies 
carried out using microanalytical methods ( Kammholz et al. , 1972; Sass a et al. , 
1973; Piomelli et al., 1973; Chisolm et al., 1974). This test had not been used for 
monitoring occupationally exposed subjects until recently. A highly significant 
correlation was found between EP and PbB in adult males under stable lead exposure. 
In this situation EP is also closely correlated with urinary lead and chelatable 
lead (Roels et al., 1975; Tomokuni et al., 1975; Alessio et al., 1976a). 
The behaviour of EP is uniform with respect to the three indicators of dose. EP 
first undergoes a modest increase with the elevation of the internal load within 
the normal values. Beyond such normal values a net increase occurs, which continues 
up to an asymptotic value which is not further altered by the increase in dose 
(Alessio et al., 1976a). 
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In adult males the increase in EP in the 40 to 80~g/l00ml blood lead range 
appears very marked, so that the difference between "normal" subjects, subjects 
with "permissible" and subjects with "not permissible" absorption appears more 
distinct than that which can be revealed by blood lead. (Fig. 6) It should be 
pointed out that at PbB levels which do not cause an elevation in EP, a reduction 
in ALAO levels is already in operation. On the other hand, the dose-response 
relationship calculation has shown that in adult males there is a no-response PbB 
level for an increase in EP of 25-35~g/l00ml (Roels et al., 1975; Zielhuis, 
l975a). The no-response PbB level for ALAD appeared to be l5-20~g/lOOml 
(Zielhuis, l975a). 
Moreover, EP permits a fairly accurate prediction of the amount of chelatable lead 
(Alessio et al., l976a). This seems particularly interesting since it is very 
likely that, as an indicator of biologically effective internal dose, chelatable 
lead is more relevant than lead in blood. 
EP can be reliably used as a screening test for monitoring occupationally exposed 
groups since it has good predictive validity in the 40-70~g/l00ml range for PbB 
and in the 500-2000~g/24h range for PbU EDTA. See Table 5, Alessio et al. (1976a). 
For example, at a blood lead level of 60~g/100ml, EP at a cut-off of 75~g/l00ml 
correctly classified 97% of positive subjects and 99% of negative subjects. Thus 
only 3% false negatives and l% false positives were obtained. 
Moreover, EP was found to correlate with other indicators of effect, suggesting 
that it could be used to predict both the internal lead load and the modifications 
of the other indicators of effect (Tomokuni, 1975; Alessio et al., 1976b). 
When examining recently exposed subjects, account must be taken of the fact that 
between the beginning of lead absorption and the increase in EP there is a time lag 
evaluated by Sassa et al. (1973) as 2 months, and by Stuik (1974)-as 2 to 3 weeks. 
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Figure 6 
Relationship between PbB and EP, in 201 adult males currently exposed to lead - r 
0.94. 
Upper frame: linear scale on ordinate. Lower frame: logarithmic scale on ordinate. 
EP determined according to the Schwartz and Wikoff Method. 
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Table 5 
A) Validity of EP for predicting different PbB levels. Analysis 
made on 201 adult males currently exppsed to lead. 
B) 
PbB EP Se Sp Validity 
( ~g/lOOml) (~g/lOOml RBC) 
~ 40 >/ 50 0.83 0.98 1.81 
~ 60 ~ 75 0.97 0.99 1.96 
>-- 70 ~ 100 0.98 0.90 1.88 
Validity of EP for predicting different PbU EDTA levels. 
Analysis made on 92 adult males currently exposed to lead. 
PbU-EDTA EP Se Sp Validity 
( ~g/24ore) (~g/lOOml RBC) 
>-- 500 ~50 0.84 1.00 1.84 
~ 1000 ~ 75 0.92 1.00 1.92 
~ 1500 ~ 100 0.96 0.97 1.93 
~ 2000 ~ 150 0.93 0.83 1.78 
Se = sensitivity, Sp = specificity, Validity= Se + Sp. 
EP determined according to the Schwartz and Wikoff Method. 
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Figure 7 
Relationships between EP and PbB (upper frame) and EP and PbU-EDTA (lower frame) in 
adult males with past lead exposure. 
Scatter diagram: individual date of past-exposed subjects. 
Logarithmic scale on ordinate. 
EP determined according to the Schwartz and Wikoff method. 
E 
0 
0 
0... 
w 
Vl 
400 
300 
200 
100 
50 
I 
I 
........ :·: ...--· 
..... ,..,. 
/ 
/ 
./ 
~~ ... ,.. 
/ .. 
I .. 
I. 
. 1 --past exposure n=67 r=0.51 
. "/ 
I." ---current exposure n=201 r=0.94 
I 
0~---.-----.-----.-----.----~----~----
0 20 40 60 80 100 120 
PbB ~g/100ml 
400 
300 
~ 200 
0:: 
E 
0 
0 
0... 
w 
100 
.Y 
;I" 
50 .""//" 
I 
·I 
I .. 
·. 
--past exposure n=67 r=0.76 
---current exposure n=92 r=O. 89 
o~---r---~---r---~-----r--
o 1000 2000 3000 4000 5000 
PbU EDTA ~g/24h 
-29-
Normalization of EP after cessation of exposure is slower than that of PbB, ALAU 
and CP. In fact, in erythrocytes of subjects who have been exposed to lead there is 
a surplus of EP which persists until the red blood cells are destroyed (Albahary, 
1972). However, in severely exposed subjects, EP stays at high levels even for many 
years after cessation of exposure (Saita eta~., 1954; Gajdos, 1957; Rubino et al., 
1958). Alessio et al. (1976c) recently demonstrated that the correlation existing 
between EP and PbB is decidedly lower in male subjects no longer exposed to lead 
than in currently exposed subjects, and that for the same PbB values, the EP levels 
are markedly higher in subjects who are no longer exposed. 
EP and chelatable lead are closely correlated both in currently exposed subjects 
and in subjects with past exposure, and the regression curve in both groups takes 
on an almost identical profile. See Figure 7, Alessio et al., (l976c). These data 
seem to indicate that EP remains at high levels for a long period of time due to a 
direct inhibition of heme synthetase by the lead released from the deposits. 
The erythrocyte metabolite can therefore be used to detect the existence of past 
exposure and to determine whether a patient who has had past exposure should resume 
work with lead. 
EP levels as high as those occurring in severe lead poisoning might be found i,n 
erythropoietic protoporphyria, a rare congenital disorder, and in thalassemia 
major. Moderate increases have been found in cases of iron deficiency, serious 
liver diseases, and tumours (Baloh, 1974; Saita et al., 1966). 
4.2.2.2 Zinc protoporphyrin 
Determination of zinc protoporphyrin with portable hematofluorimeters is a very 
practical test which is easier to perform and lower in cost than the extractive 
methods. 
There is a very close correlation between ZPP and PbB in adult males: The 
regression curve between the indicator of exposure and effect takes on the same 
profile as already observed for EP (Fig. 7); in fact, at PbB levels below 35-40 
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11gllOO ml, ZPP undergoes only a moderate increase, but subsequently the increase 
is very marked (Schaller and Schiele, 1977; Alessio et al., 1978) (Fig<.8). 
Without cases having PbB levels above 90 11 g/ml it is not possible to check 
whether the regression curve takes on the asymptotic slope observed for EP 
determined with the Schwartz and Wikoff method. 
Research in progress in our laboratory has shown a high predictive validity of ZPP 
and PbB levels ~ 60 11gllOO ml: using a cut-off of ZPP ~ 80 11 g/l00 ml 
validity was 1.77, with very hinh sensitivity (0.98), signifying 2% false 
negatives. The test may therefore ue used to advantage in screening studies of 
occupational exposed subjects. Such studies are facilitated by the fact that the 
instrument is portable, gives immediate results and allows a large number of 
subjects to be examined in a short time.· 
It should however be noted that this test has been in routine use for a short time 
only so that certain features must be studied more closely. 
As the hematofluorimeter takes account of the absorption spectrum of oxyhemoglobin, 
the ZPP levels determined on capillary blood are decidely higher than those 
determined on venous blood; whereas they are identical to those determined on 
venous blood after oxygenation (Alessio et al., 1978). 
A close correlation exists between ZPP and EP; but it should be noted that while 
Alessio et al., (1978) found that EP levels, determined according the Piomelli 
method, were higher than ZPP levels, Blumberg et al.,(l977) found that ZPP levels 
were higher than EP levels, and Schaller and Schiele ( 1977) found that ZPP levels 
were practically identical to erythrozyte protoporphyrin levels. A tentative 
explanation of the discrepancy in results might be the use of a different standard, 
the analytical values of erythrozyte protoporphyrin are lower (about 50%) than 
those obtained using a protoporphyrin standard. 
It should moreover be noted that the research in progress in our laboratory has 
shown that by using three hematofluorimeters of different make, significantly 
different values are obtained (Fig. 9). 
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Figure 8 
Relationship between PbB and ZPP in 211 adult males currently exposed to 
lead. ZPP determined with an ESA 4000 apparatus. 
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Figure 9 
Relationship between ZPP values obtained using different makes of 
hematofluorimeters. 
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Figure 10 
Relationship between PbB and indicators of effect in adult males currently 
exposed to lead. 
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Figure 11 
Range of ALA concentrations in individual urine samples passed by the same 
children in a single 24 hour period. Data are shown for 25 children with 
blood lead concentrations ranging between 23 and 75 \lg PbS. Each vertical 
bar represents data from a single child and each solid circle on the bar 
represents the concentration of ALA ( \lg/ml) found in separate specimens from 
that child during a single 24 hour period. The wide range of concentration of 
ALA in single voidings of urine is apparent. 
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It is to be hoped that hematofluorimeter manufacturers carry out a joint study as 
soon as possible to standardize the calibration of the instrument, so that ZPP 
values may be read1ly co1npared in all laboratories. 
4.2.5 uelta-amlnolevulinic acid in urine 
Uue to tne inhibition of the ALAD of the maturing R8C's by lead, the transformation 
of MLA into prophobilinogen is obstructed, resulting in an increase in ALA in the 
serum ana in the unne. On the subject of behaviour of ALA in the serum, a few 
studies of children with acute encephalopathy are available. However, at present 
1 t aoes not apf.Jear that the test can be used routinely, since detection of only 
mooerately increased levels of ALA requires more than lOml of plasma (Chisolm, 
101/5). 
Many stuoies are, however, available on ALAU. Researchers have found a goad 
correlatwn between the urinary metabolite, PbS and PbU (Williams et al. , 1969; 
Selander and Cramer, 1970; Haeger-Aronsen, 1971; Soliman et al., 1972; Lauwerys et 
al., 1974). The coefficient of correlation between PbS and ALAU is usually between 
lJ .5 and 0. 7, ana therefore is not as close as the correlation which generally 
ex1sts between PbB and the blood tests (ALAD and erythrocyte protoporphyrin). A 
s1~ru f1cant 1ncrease in ALAU can be seen at PbS levels slightly higher than those 
at which tnere is an increase in erythrocyte protoporphyrin values. See Figure 10, 
luessw et al. (l976b). This phenomenon is clearly seen from examination of the 
aose-response relationship. In fact, the approximate no-response PbS level for ALAU 
is )5-4>~g/llJUml, while for FEP it is 25-35~g/100ml (Roels et al., 1975; 
21elhU1S 1 1975b). 
t:rythrocyte protoporphyrin perm1ts better aiscrimination between exposed workers 
with "permissible" absorption and those w1th "potentially dangerous" absorption 
tnan ALAU. In fact, at a PbS concentration below the currently accepted TLVs, the 
progresslVe elevation of erythrocyte protoporphyrin is more marked than that of 
ALAU. See Figure 10. It shoula be noted, however, that the levels of ALAU, like the 
levels of CPU, also undergo increasing elevation when PbS values exceed 
ClU-Oillllg/lOOml, while erythrocyte protoporphyrin values do not undergo any further 
-36-
Increase. (This phenomenon has not yet been verified for ZPP). Therefore, urinary 
tests may have an important application when metabolic damage such as that which 
car1 occur in leao intoxication must be evaluated (Alessio et al., l976b). 
Like the validity of CPU, the valioity of ALAU for predicting PD8 appears to be 
DIStinctly lower than that of erythrocyte protoporphyrin. 
To preuict a Potl level >; 60 ~g/lUU ml using a cut-off of ALAU >; 10 mg/1, 
validity was 1.67, with sensitivity= 0.75, and specificity= 0.52; the number of 
false negatives IS therefore very high (25%) (Alessio et al., 1976b). 
In recently exposed subjects, there is a latency period of about two weeks before 
tne urinary metabolite increases (Tola et al., 1973; Benson et al., 1976). 
A tter cessation of lead exposure, the excretion of ALA in the unne becomes 
"normal" relatively quickly. This parameter is therefore not suitable for detecting 
past lead exposure (Haeger-Aronsen et al., 1974). 
For Ure uetermination of ALAU, as for all the other urinary tests, it is difficult 
to obtain L4-nour urine samples or urine samples for precise periods of time, e.g. 
'l-b hours. Generally the determination is therefore per formed on spot samples. 
Uwwg tu the different density of daily samples, widely varying levels of the 
rnetaoollte e.g. from "normal" to "pathologic" can be obtained from tile same 
subject. For an example, see Fi1,1ure 11, Chisolm et al. (1~76). To overcome this 
dltf1culty, tile sample is currently corrected according to its specific gravity or 
creatinine. This correction will probably be useful in studies on groups of 
subJects, out w s1ngle subjects it does not permit approximation of the value 
obtained with respect to the ALA present in 24-hour urine samples (whether 
expressed In mg/1 or mg/24h). 
The 1-\LAU values reported in the 11 terature for the subjects not occupationally 
exposed to lead are below 6mg/l or 4.5mg/g of creatinine. High values of ALAU can 
also be found in subjects with acute intermittent porphyria. 
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Various chromatographic and non-chromatographic methods are available for the 
determination ot ALAU. A critical evaluation of some of these techniques has been 
maue by koels et al. (l~?4b). 
4.L.4 Coproporphyrin In Urine 
ln subjects under continuous exposure, there is a good correlation between PbB and 
CPU ( •1illlams et al. , 1969; Soliman, 1972; Alessio et al. , 1976b). 
An excretion of coproporphyrins in the urine (mainly isomer III) beyond the upper 
normal limits occurs when the PbB levels are slightly higher then those at which an 
InLrease in ALAU values occurs. See Figure 10. This phenomenon is also evident in 
the examination of the dose-response relationship between the two urinary 
n11otaboll tes and Pbt:J ( Wada, 1976). 
Frrnn commencement of exposure to increase in CPU there IS a time lag of about 2 
weeks In recently exposed subjects (Tala et al., 1973a; Benson et al., 1976). With 
cessation of exposure, the urinary coproporphyrins return to normal within a few 
weeKs and sometimes within a few days (Saita, 1962). 
unnary coproporphyrin is not a specific test of lead exposure. Increases in the 
unnary metabolite may occur also in porphyria cutanea taroa, cirrhosis, liver 
disease, natomolytic anaemia, malignant blood diseases, infectious diseases, and 
also after consumption of alcohol. However, subjects with severe lead exposure may 
In some rare cases show normal levels of coproporphyrin in the urine (Saita et al., 
1~66; Lauwerys, 1975). 
Tne same limitations given for ALAU apply for this test as well. 
The valioity of CPU (determined on spot samples) to predict different PbB levels is 
rather modest, so its use as a screening test is limited (Alessio et al., 1976b). 
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Other porphyrins are not as common in urine, although increased uroporphyrin levels 
may occasionally oe detected, especially in severe cases of lead poisoning 
(Stankovic et al., 1973). 
4 . ..::.5 Hae111oglobin anu stippled cells 
These two tests are only marginally important for the routine monitoring of lead 
exposure. Haemoglobin and PbB are generally poorly correlated; a reduction in Hb 
occurs when the Pt:Jb level exceeds 100-llO~[,J/lOOml (Williams, 1966; Cooper et a1., 
10173). 
ln the past, stippled cell count was "an early indicator of abnormal lead 
absorption", since the appearance of stippled cells precedes the onset of anaemia 
(Sarta, 1962). This test is not used tOday because it does not accurately reflect 
the amount of lead absorbed and because the number of stippled cells increases with 
a much greater time lag than the other biological changes aiscussed above 
(Lauwerys, 1975). Furthermore, the test is not speci fie for lead intoxication 
srnce stippled cells may be present in thalassemia, pernicious anaemia and anaemia 
uue to renal insuffrciency (Saita, 1962). 
4.3 lr1cJ1cators of Effects rn Adult Females 
because of its relatively recent rnterest, the number of studies of female 
exposures rs rather limited. They generally involve a small sample of subjects with 
a moaerate degree of exposure. 
4.5.1 Erythrocyte delta-aminolevulinic acrd dehydrase (ALADJ 
~tudres maae on groups of subjects not occupationally exposed have shown that adult 
females living in the same place and of the same age as a group of male controls 
had a hrgher mean value of erythrocyte ALAD activity and a lower mean value of lead 
in blood (Haeger-Aronsen et al., 1971; Secchi et al., 1973). 
In the women it was also observed that the reduction in ALAD activity with age is 
less marked than in men (Secchi and Alessio, 1974b). The differences found between 
the two sexes was attributed to a different lead intake with food, wine, and 
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smoking. Tala (1973), who examined 171 women and 1199 men with PbS levels between 
'J ana :>Uug/ lllUml, found no consistent differences between the ALAD values of men 
ana women at the same blood levels. Similar results have been obtained in a study 
of 'J) women ana 'J5 men with Pbb levels ranging from 8 to 80 ug/lOOml (Alessio et 
al. , l'} 77). From these data It therefore appears that there are no differences 
b~tween males ana females with the same level of internal lead load. 
4.3.2 Erythrocyte protoporphyrin 
Stuik (b74) has shown that increase in EP occurs in aault females at a lower 
concentration of PbB than in adult males (for females at a PbS level of 
25-35ug/llJUml; for males at 35-45ug/100ml), and that the increase in EP was 
steeper in females with the increase in PbS values. 
~P was observed to behave similarly by Roels et al. (1975) in 40 male and 24 female 
aaults with macerate occupational exposure (PbS 5llug/l00ml). EP and PbS were 
closely correlatea in the two groups; EP was markedly higher in the women at the 
same internal lead dose, i.e. PbB. Tnis phenomenon can also be clearly observed in 
the groups considered in a stuay by Alessio et al. ( 1977), see Figure 12, which 
cor1Sisteu of suojects witn more severe exposure. Similar results are obtained when 
erythrocyte protoporphyrin is determined with hematofluorimeters, like ZPP. 
Stuoy of the oose-response relationship does however show that the no-response PbS 
levels for an increase in EP are 25-35ug/l0Dml for males and 20-30 ug/ lOOml for 
females (Roels et al., 1975). 
In women, EP IS also well correlated with chelatable lead (PbU EDTA). The 
regresswn curve between the erythrocyte metabolite and PbU EDTA, shows that for 
the same level of internal dose, EP is higher in females than in males, even when 
the internal dose is measured by chelatable lead (Alessio and Foa, 1976). 
In non-occupationally exposed women, the EP levels are higher than in males (Roels 
et al., 1:175; Wibowo et al., 1977). 
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Figure 12 
Relationship between PbB and EP in adult males and females. 
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4.3.3 Uelta-aminolevulinic acid in urine (ALAU) 
ln occupatwnally exposed women, ALJ.\U ana PbB are well correlated. Levels of the 
urinary metabolite in the women seem slightly higher than in men, at the same PbB 
level (Koels et al., 197~). 
:otuay of the dose-response relationship shows that the no-response levels for an 
Increase 1n ALJ.\U are 35-45~g/l00rnl for males and 3ll-40~g/l00ml for females 
(Roels et al., 1975). It does not, however, appear that there is a significant 
Difference tor ALAU values in non-occupationally exposed subjects in the two sexes. 
4.3.4 Urinary Coproporphyrin 
Kesults by Alessio et al. (1977) show that CPU and PbB are significantly 
correlateo. The relationship between the two parameters does not seem to indicate 
the existence of a difference in behaviour of the urinary metabolite in the two 
sexes. 
From tne available data on aoult women, the following conclusions can be drawn: 
In aoult women a significant correlation exists between the indicators of 
internal lead aose ana inaicators of effect, as has already been confirmed 
w adult men. 
the relationship between indicators of dose ana indicators of effect, 
evaluated with the regression curve and/or the dose-response curve, shows 
tnat In the female, the "qualitative" behav10ur of the indicators of 
effect is identical to that observed in males. In males the erythrocyte 
ALAU unoergoes a distinct inhibition in the range of PbB values below 
4U~g/100ml. The erythrocyte protoporphyrin initially increases rather 
moderately; then, beyond a PbB level of 4U~g/lOOml, the increase is very 
marked. ALAU and CPU increase above normal for PbB values higher than 
tnose at which an increase in protoporphyrin occurs. The increase in the 
two urinary metabolites in relation to the increase in internal lead load 
IS not as steep as the increase in the erythrocyte metabolite. 
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There is a clear difference in the "quantitative" behaviour of 
protoporphyrln (and perhaps of AL~U) in the two sexes at identical levels 
of internal dose. This phenomenon appears to be due to a greater 
susceptioility of haemopolesis to lead in women. The cause of such 
nypersensitivity might be a relative iron aeficiency in women, causing 
increased alterations in haemopoiesis induced by lead (~tuik, 1974; 
Lielhuis, 1975a). Synergic action between sex hormones and lead on the 
enzymatic activity of heme synthesis has also been suggested (koels et 
al., 1975). 
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5.0 CONCLUSIONS 
A vast number of tests which permit a sufficiently accurate evaluation of the 
degree of exposure, oody buraen and toxic effect are available for monitoring lead 
workers. G1ven the advantages ana limitations of each test, the choice of indicator 
or lndicators w111 depend on the type of investigation. 
Two tests should be used s1multaneously for the periodic surveillance of workers 
exposed to lead concentrations sufficient to cause alterations in biological 
wmcators close to the "permisslble" llmits. One test should be designed to 
wdlcate 1nternal aose and another to indicate effect. In mom taring individuals, 
olood tests are preferable to urinary tests, the latter being subject to 
cons1derab1e variation due to differences in urine density. Furthermore, elevation 
beyond tne "normal" limt values of tne urinary indicators of effect, (i.e. 
delta-am1nolevulinic acid and coproporphyrin), occurs at internal dose levels 
h1gner than those at which an alteration occurs in the blood indicators of effect, 
(l.e. delta-aminolevulinic acid dehydrase activity of erythrocytes (ALAD) and 
erytnrocyte protoporphyrin). 
In general, it is adv1sable to use blood lead levels and erythrocyte protoporphrin 
for per1odic mon1torin~ as these two tests integrate well. This is not only because 
one evaluates internal dose and the other the effect but also because blood lead 
evaluates a momentary situation (present exposure) while the erythrocyte metabolite 
permits evaluatwn of body our den and past exposure. These features are important 
in relation to the fact that industrial levels of exposure are rarely stable, so 
tnat PbtJ alone m1ght give only partial information in cases of non-steady-state 
exposure. On the other hand, protoporphyrin does not permit assessment of current 
aosorptwn. 
A screen1ng test which is inexpensive, easy to perform, sensitive, speclfic, 
precise ano accurate should be used to identify subjects with the highest exposure 
from a group. The percentage of false negatives should be minimal, but too many 
false pos1t1ves may give rise to excessive referrals for diagnostic evaluation, 
cause alarm and overcrowo busy outpat1ents facilities (Chisolm et al., 1974). Both 
eryU1rocyte protoporphyrin and delta-aminolevulinic acid dehydratase comply on the 
whole with these requirements: both tests have been shown to possess high 
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predictive validity of the "true situation", i.e. internal lead load measured with 
Poi:J. 
Protopor~hyr1n offers the follow1ng advantages over ALAD: a) it also permits 
quantification of situations in which an internal lead load has already caused a 
markea inh1bition of ALAD; b) it can be measured using capillary blood w1th 
m1cromethous which are rapid to perform. The fluorimetric zinc protoporphyrin 
technique a[Jpears to offer a simple, instant ana repeatable measurement; c) a 
n1gher numoer of analyses can be performed in the course of the day; d) the sample 
for analys1s can be stored for longer periods of time. 
The ur1nary tests may be used for assessment of the environmental conditions of a 
place of work on a g1oup basis, although olood tests previae more accurate 
1nformation. If urinary tests are used, it will be appropriate to take the aensity 
of the Sctmples into account, reJectiny tnose with density lower than lCJlO, or w1th 
creat1n1ne concentration below 0.5 g/1. 
For a correct evaluauon ot a group investigation, it will not be sufficient to 
express the oata solely as a mean (i) and stanaard deviation (a) or range. This 
procedure can be applied only if the parameter follows a Gaussian distribution, and 
it w1ll be appropr1ate to consiaer the percentage distribution of the aata as well 
(Zielhuis, 1974). 
The choice of b1ological tests must also be made on tne basis of the availability 
of suitaole equipment and trained technical staff, the possibility of easy and 
rctpld performance, transport and cost. 
The problem of "permissible" levels of owlogical tests for workers exposed to 
1norganic lead has been considered by many authors and by national and 
1nternationaL bodies responsible for the protection of workers health, and has been 
a1scussed at numerous meetings of experts. 
ln September 197b a worksnop was organized in Amsterdam unaer the auspices ot the 
Permanent Commission and International Association on Occupational Health and the 
worLa Healtn Organization, which re-examined tne problem of permissible limits for 
occupational exposure in inorganic lead (Zielhuis, 1977). 
-45-
~t the workshop the following recommended guidelines for PbB based on health 
en tena were or awn up: "for male workers inoi vidual PbB 's should not exceed 
60~g/ lUUml 1n the lighc of present knowledge available to this group. It is 
however desirable to reduce individual exposure below this level, taking into 
account the effects on tne haematopoietic system at concentrations above 
4:>-50~g/ luuml ana on nerve conduction velocity at concentrations between 
:>0-6u~g/ lUUml. The group could not agree on what level should be regarded as a 
health based permissible level for occupational exposure. So far as female workers 
of c11ild-bearing age are concerned the r lsk of harm to the foetus at above 
mentioneo Pol:l levels is not supported by factual evidence but is based on 
theoretical possibility. Nevertheless, because of potential effects on tne foetus, 
a safe practice woulo oe to avoid the employment of women of child-bearing age on 
lead work where blood levels miijht regularly exceed 4U~g/l00ml." 
ln 197b, s1m1lar recommer1dations were also made in the U.S.A. by the National 
lnstltute tor OcCUIJational Safety and Health (NIOSH, 15178), and by the Italian 
soc1ety of Occupational Medicine and Industrial Hygiene (Foa et al., 1978). 
The to11ow1ng 1s a summary of the main recommendations made in the Italian document 
whlch contains many practical suggestions. 
For evaluation of r1sK for individual workers, the following tests are proposed as 
being the most suitable: 
lead in blood and urinary ALA, to evaluate respectively dose and effect 
relative to current exposure; 
erytnrocyte protoporphyrin to quantify an effect due also to past exposure. 
On the basis of increasing values of the biological tests, 4 different classes 
shoulo be distingu1sheo: 
-lst class: 
-..::no class: 
-5ro and 4th classes: 
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no action 
surveillance 
increasingly important action: 
the need for action depends on consideration of the 
fact that subjects with values of the indicators 
persistently at tnese levels coulo oevelop a 
pathological condition. 
lnoicatlons for the exposure of male subjects to lead are given more schematically 
ln Table 6. 
The anginal document gave no values for erythrocyte protoporphyrin since the 
authors thougnt it advisable to wait for further data on this. The zinc 
protoporpnynn (LPP) values snown in the table are those currently used at the 
Llinica del Lavoro of l~ilano. 
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Table 6 
~cheme of medical and environmental measures for increasing occupational 
exposure to lnorganic lead. 
lndlcators 
-------
Pbb ~"/lOU ml 
1-\LAU mg/l 
L:.PI-' ~g/lUU ml 
Individual 
measures 
Envuonmental 
measures 
I 
>40 
> 6 
>40 
Annual 
check of 
biological 
indicators 
None 
The document also states that: 
Classes 
II 
40-6U 
6-10 
liJ-110 
3-monthly 
check of 
biological 
indicators 
Check of 
working 
environment 
of exposure 
III IV 
60-70 <70 
10-18 <18 
110-170 <170 
Removal from Removal 
risk; from job; 
exami- study and any 
nation and treatment by 
tests as specialists 
for pre-
employment 
Technological and environ-
mental improvement 
necessary 
classification is to be maoe on the basis of a single indicator in 
the greatest risk class; 
persistence for at least three months of protoporphyrin values 
higher than those of the class corresponding to PbB and ALAU 
levels (when an iron deficiency can be excluded) denotes the 
existence of lead deposits in the organism such as to cause 
biological effects. 
The occupational Safety and Health Administration, u.s.A., (OSHA, 
1~78) has issued a standard that requires permissible PbB levels to be 
progressively lowered to 40 ~g/100 g over the next 5 years. 
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6.0 RESEARCH NEEDS 
In spite of the fact that lead is the most extensively studied metal from the point 
of v1ew of industrial toxicology, further research is still necessary to establish 
safe permissible limits for exposure. The following are recommendations for further 
research: 
::,tandaroization of tests. Stanaardization of analytical methodology would 
allow a comparison of the studies being carried out by the d1 fferent 
laboratones ana research workers and woula facilitate d1scussion and 
appl1cation of normal values and permissible limits internationally. 
~s a result of the inter-laboratory variability of lead blood levels, the 
reldtionshlp between these levels and other biological indicators cannot be 
prec1sely determined. 
The opinions of the various research workers on the usefulness of 
correcting 
conflicting. 
the results of urinary tests made on spot samples are 
This question should be dealt with to verify whether the 
corrections made for the individual subject allow a value to be obtained 
wh1ch is sufficiently similar to the value obtawed on the same day on 
24-hr urine (considering the value expressed as quantity of substance per 
l1tre and/or quantity of substance per 24 hours). 
Daily variatwns in tl1e results obtainea from the various biological tests 
should oe wvestigated as there are very few references to this in the 
literature (Vigliani and Bonsembiante, 1944). 
l.leterrninatwn of the relationship between external and internal exposure. 
More extensive stuaies involving larger groups of subjects and taking 
particle s1ze and solubility into consideration are necessary for this 
aeterminatwn. 
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t.stablishment of better indicators of internal lead dose. Very few studies 
are available on lead in plasma although diffusable plasma lead may offer 
the best approximation of the biologically effective body burden. It should, 
however, be taken into consioeration tnat the plasma fraction is not a 
constant fraction of the total blood concentration. 
Chelatable leao may provioe a more direct measurement of the rapid exchange 
pool ana it may be used as a rough measure of plasma lead concentrations, 
s1nce it is normally found in plasma and not in cells. It therefore appears 
necessary to determine tne oose-effect relationships between chelatable lead 
ano other 1noicators. 
The oose and rate of administrations of chelating drugs for estimating the 
mobile port1on of the oody lead burden should also be standardized. 
Research on hypersensitivity to lead. The few data available in the 
literature (Saita and Mo:eo, 1959; Girard et al., 1967; Albahary, 1972; 
Saita and Lussana, 1971), inoicate that subjects with genetic alterations 
(thalassemia, haemoglobinopathy, G6PD deficiency) may be hypersensitive to 
tne action of leao. The high incidence of these alterations in some 
countries of the European Community ana the increasing transient population, 
e.g. immigrants from the Meoiterranean area, point to the necessity of a 
re-examination of the problem. 
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